Akeso’s Gumokimab Monoclonal Antibody (IL-17) New Drug Application for the Treatment of Moderate to Severe Psoriasis Accepted by NMPA by Investing.com
Hong Kong, January 26, 2025 /prnewswire/- Akeso, Inc. (9926.hk)("AkesoThe Company (or the…
EXCLUSIVE: Influencer Charlie Michael Baker Had The “Most Soul Destroying” Experience After a Collaboration Gave Him “Worst Case” of Psoriasis
There are only a handful of Indian films that defy the conventional…
